Published 10 hours ago • loading... • Updated 10 hours ago

Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies

Cellares is partnering with Stanford Medicine to automate gene-edited stem cell therapy for HIV and more than 19 rare diseases.

Cellares is partnering with Stanford Medicine to automate gene-edited stem cell therapy for HIV and more than 19 rare diseases.

10 hours ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated7 hours agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

pharmtech.com broke the news in 10 hours ago on Tuesday, February 3, 2026.

Sources are mostly out of (0)